Receptors for thymosin alpha 1 on mouse thymocytes.
Rinaldi Garaci. C C; Torrisi. M R MR; Jezzi. T T; Frati. L L; Goldstein. A L AL; Garaci. E E
Key Findings
- Thymosin‑alpha‑1 binds to the surface of many mouse lymphocytes.
- Immature (PNA+) thymocytes display specific receptors for thymosin‑alpha‑1.
- Binding likely represents the initial step by which the peptide activates T‑cells.
Practical Outcomes
- For biohackers, this confirms that thymosin‑alpha‑1 can directly interact with immune cells, supporting its use as an immune‑modulating supplement. However, the work is in mice, shows no dosage or safety data, and does not provide concrete protocols for human use. More human‑focused research is needed before applying these findings to personal health regimens.
Summary
The study shows that the peptide thymosin‑alpha‑1 can stick to the surface of mouse immune cells, especially the young T‑cell precursors, suggesting it works by directly binding to cell membranes.
Abstract
Thymosin alpha 1 is able to act in vitro to stimulate T-cell precursors and to induce surface markers. The initial mechanism by which alpha 1 activates T cells could be the binding of alpha 1 to cell membranes. Using a specific anti-alpha 1 antibody and an indirect immunofluorescence procedure it was found that thymosin alpha 1 binds to the surface of a large portion of murine lymphocytes. Furthermore, thymocytes have been fractionated into immature and mature subpopulations by using the peanut agglutinin (PNA) technique. It was found that PNA+, immature cells showed specific receptors for alpha 1 on the cell membrane.
Study Information
pubmed
1985
1985-03-01T00:00:00.000Z
10.1016/0008-8749(85)90051-6
18
10